Kidney Disease Clinical Trials in Houston

Showing 261-280 of 349 trials

Propaten Randomized Investigation on Cost-benefit and Efficacy

NCT01601873

The purpose for this study is to evaluate the patency and outcomes of conventional and heparin anticoagulant bonded arteriovenous grafts in patients with end stage renal disease.

End-stage Renal Disease

The University of Texas Health Science Center, Houston103 participantsStarted Nov 2012

Little Rock, Arkansas, United States • New Orleans, Louisiana, United States • Cleveland, Ohio, United States +2 more locations

COMPLETEDPhase 3< 1 mile

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

NCT00975000

Hyperparathyroidism (HPT) is common in people with a kidney transplant. Patients with HPT often have high parathyroid hormone (PTH) levels and may have large parathyroid glands in the neck. Patients with HPT can develop bone disease (osteodystrophy). This bone disease can cause bone pain, fractures, and poor formation of red blood cells. Other problems from HPT may include increases in blood levels of calcium (hypercalcemia) and low blood levels of phosphorus (hypophosphatemia). The high calcium levels may cause calcium to deposit in body tissues. Calcium deposits can cause arthritis (joint pain and swelling), muscle inflammation, itching, gangrene (death of soft tissue), heart and lung problems or kidney transplant dysfunction (worsening of kidney transplant function). The purpose of this study is to evaluate the effects of cinacalcet (Sensipar/Mimpara) on high calcium levels in the blood in patients with HPT after a kidney transplant.

Chronic Allograft NephropathyChronic Kidney DiseaseChronic Renal Failure+7 more

Amgen114 participantsStarted Dec 2009

Phoenix, Arizona, United States • Tempe, Arizona, United States • San Francisco, California, United States +48 more locations

Propaten Randomized Investigation on Cost-benefit and Efficacy

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Kidney Disease Trials in Other Cities

Personalized Targeted Inhibitors Treatment in Renal Cell Cancer

A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT

Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma

Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1

Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa

A Study of LY3113593 in Participants With Chronic Kidney Disease

A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

A Study of LY2928057 in Hemodialysis Participants

Other Conditions in Houston